W STRATEGIES, LLC for ABBVIE INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1101: Viral Hepatitis Testing Act. Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars, including patent dispute resolution. Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures). Education about the value of innovative new medicines. Education about the 340(b) program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Copyright/Patent/Trademark CPT
H.R. 9: Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education and outreach about the competitive elements of the Medicare Part D drug benefit and opposition to legislation imposing Medicaid style manufacturer rebates in the program. H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.